Sialidase-Based Anti-Influenza Virus Therapy Protects against Secondary Pneumococcal Infection. (J Infect Dis., abstract, edited)

3. J Infect Dis. 2010 Feb 19. [Epub ahead of print]

Sialidase-Based Anti-Influenza Virus...